Monique Minnema works at the University Medical Center Utrecht Cancer Center, The Netherlands. She specialises in the diagnosis and treatment of B cell malignancies, especially plasma cell dyscrasias, like multiple myeloma, AL amyloidosis, and Waldenström’s Macroglobulinemia. She is the chair of the Dutch guideline for diagnostics in multiple myeloma and the guideline for the treatment of AL amyloidosis. She initiated and supervises the hematology clinical research team, which coordinates and supports all clinical studies conducted in the department of hematology. Her main focus of clinical research is the development of novel therapies (both cellular and drug) for plasma cell dyscrasias and lymphoma. In 2019, 2020 and 2021 she organized the first Dutch symposia on “Innovations in Cellular Therapy” and the multidisciplinary symposia for Systemic Amyloidosis.
EM-93999 - Date of preparation: March 2022